BPC-157 for Inflammation
Research, mechanism, dosing, and effectiveness of BPC-157 for inflammation.
Quick Answer
BPC-157 has demonstrated anti-inflammatory effects across multiple tissue types. It modulates inflammatory pathways and promotes resolution of inflammation.
Evidence Level
Animal Studies
Typical Dose
250-500 mcg once or twice daily
Results Timeline
1-4 weeks for anti-inflammatory effects
FDA Status
Research Only
How BPC-157 Works for Inflammation
Regulates nitric oxide production, modulates inflammatory cytokines, and promotes tissue repair pathways.
About Inflammation
Reduction of chronic inflammation and inflammatory responses in the body.
Research Evidence
Extensive preclinical studies demonstrate efficacy in healing tendons, ligaments, muscles, and the GI tract. 2025 AJSM systematic review: Of 544 articles screened, only 1 clinical study met inclusion criteria (rest were animal studies). Only 3 small human pilot studies exist (fewer than 30 total subjects). No pharmaceutical company has initiated FDA trials due to lack of patentability. FDA placed BPC-157 in Category 2 in September 2023.
Dosing for Inflammation
Recommended Dose
250-500 mcg once or twice daily
Frequency
1-2x daily
Administration
Subcutaneous injection near injury site, or systemic
Duration
4-12 weeks in most research protocols
Note: Often injected subcutaneously near injury site for localized healing. Systemic administration also common. Many users split into morning and evening doses.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated in preclinical studies
- •Nausea
- •Dizziness
- •Injection site reactions
- •Fatigue
- •Headache
Frequently Asked Questions
Does BPC-157 help with inflammation?
BPC-157 has demonstrated anti-inflammatory effects across multiple tissue types. It modulates inflammatory pathways and promotes resolution of inflammation.
How does BPC-157 work for inflammation?
Regulates nitric oxide production, modulates inflammatory cytokines, and promotes tissue repair pathways....
What dose of BPC-157 should I use for inflammation?
250-500 mcg once or twice daily
How long until I see results?
1-4 weeks for anti-inflammatory effects
Other Peptides for Inflammation
These peptides are also researched for inflammation.
TB-500
PreclinicalA synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
GHK-Cu
Clinical TrialsA naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Widely used in skincare for its wound healing and anti-aging properties.
Pentadecapeptide
PreclinicalThe full 15-amino acid sequence that includes BPC-157. While BPC-157 is more commonly discussed, the full pentadecapeptide has similar healing properties derived from gastric juice.
Thymosin Beta-4
Clinical TrialsThe full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues, TB-4 has a shorter half-life (~2 hours) compared to its synthetic fragment TB-500 (~2-4 days). Often mislabeled as 'TB-500' by vendors in premixed products.